Millions in funding and new board members for Belgian mRNA company
The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing.…
August 24, 2022 - 3 minutes
eTheRNA
How can vaccines keep up with evolving Covid-19 variants?
Vaccines for COVID-19 have saved lives all over the world, but their protection is threatened…
July 28, 2022 - 7 minutes
Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…
June 15, 2021 - 5 minutes
Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost
Belgian biotech eTheRNA has secured €34M in Series B funding to progress to the clinic…
June 18, 2020 - 3 minutes
Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
March 30, 2020 - 7 minutes
What Does the Largest Biotech IPO Ever Mean for European Biotech?
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The…
December 11, 2018 - 3 minutes
Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
June 30, 2017 - 2 minutes
Infographic: Who’s who in the mRNA Therapeutics Field in Europe?
The young field of mRNA therapeutics is booming and generating huge expectations. Which are the main players…
April 26, 2017 - 1 minute
